1/29
07:41 am
cbio
Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Medium
Report
Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
1/28
07:03 am
cbio
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
High
Report
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
1/24
12:30 am
cbio
Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at
Wall Street
Medium
Report
Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at
Wall Street
1/22
07:48 am
cbio
Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Low
Report
Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
1/21
07:17 am
cbio
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Low
Report
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
12/4
05:03 pm
cbio
Crescent Biopharma (NASDAQ:CBIO) was given a new $32.00 price target on by analysts at Stifel Nicolaus.
Medium
Report
Crescent Biopharma (NASDAQ:CBIO) was given a new $32.00 price target on by analysts at Stifel Nicolaus.
11/25
01:49 pm
cbio
Crescent Biopharma (NASDAQ:CBIO) had its "sell (e-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Crescent Biopharma (NASDAQ:CBIO) had its "sell (e-)" rating reaffirmed by analysts at
Weiss Ratings.
11/19
01:17 pm
cbio
Crescent Biopharma (NASDAQ:CBIO) had its "sell (e-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Crescent Biopharma (NASDAQ:CBIO) had its "sell (e-)" rating reaffirmed by analysts at
Weiss Ratings.
11/16
01:09 am
cbio
Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at
Wall Street
Low
Report
Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at
Wall Street
11/13
01:25 pm
cbio
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at
Weiss Ratings. They set a "sell (e-)" rating on the stock.
Low
Report
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at
Weiss Ratings. They set a "sell (e-)" rating on the stock.